An FDA committee’s September 2024 vote to limit the use of Merck’s Keytruda and BMS’ Opdivo in stomach and esophageal cancers ...
Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four ...
Oral Presentation Presented at ASH 2024 Showed Iopofosine I 131 Achieved an 83.6% ORR and Exceeded Primary and Secondary Efficacy Endpoints in ...
Spatial transcriptomics was named the method of the year in 2020 (Nature 2021). Spatial transcriptomics has rapidly emerged ...
In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report), with a ...
The mining industry is undergoing a profound transformation, driven by advancements in precision technology and innovative approaches to tailings management. These advancements are not just ...
Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...
Geode Capital Management LLC acquired a new position in shares of MBX Biosciences, Inc. (NYSE:MBX – Free Report) in the 3rd quarter, HoldingsChannel reports. The fund acquired 22,269 shares of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback